Sedative, hypnotic or anxiolytic use, unspecified with withdrawal
ICD-10 F13.93 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic use, unspecified with withdrawal.
F13.93 refers to a condition characterized by the use of sedative, hypnotic, or anxiolytic substances that leads to withdrawal symptoms when the substance is reduced or discontinued. This code is used when the specific substance is not identified, but the patient exhibits signs of withdrawal, which may include anxiety, tremors, insomnia, and other physical symptoms. Withdrawal from these substances can be severe and may require medical intervention. The condition is often associated with a history of substance use disorder, where the individual has developed a tolerance to the substance, leading to increased consumption and dependence. Treatment typically involves a medically supervised detoxification process, followed by rehabilitation programs that may include counseling, behavioral therapies, and support groups to address the underlying addiction and prevent relapse.
Detailed patient history, substance use patterns, withdrawal symptoms, and treatment plans.
Patients presenting with withdrawal symptoms after cessation of sedatives or anxiolytics.
Ensure accurate documentation of the patient's substance use history and any co-occurring disorders.
Comprehensive mental health evaluations, including assessment of withdrawal symptoms and treatment response.
Patients with anxiety disorders who misuse sedatives and present with withdrawal symptoms.
Document any psychiatric evaluations and treatment adjustments made during withdrawal.
Used when assessing a patient for withdrawal symptoms.
Document the assessment findings and treatment recommendations.
Ensure that the assessment aligns with the diagnosis of F13.93.
Common symptoms include anxiety, tremors, insomnia, sweating, and in severe cases, seizures. These symptoms can vary in intensity based on the duration and amount of substance used.
